February 29, 2024 Comments Off on New patent expiration for Mylan Speciality drug DYMISTA Posted in: Uncategorized
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. There are four…
The post New patent expiration for Mylan Speciality drug DYMISTA appeared first…
February 29, 2024 Comments Off on Drug Patent Expirations for the Week of February 25, 2024 Posted in: Uncategorized
DYMISTA (azelastine hydrochloride; fluticasone propionate) Mylan speciality lp Patent: 8,163,723 Expiration: Feb 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Pate…